AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human TrialM. Scott Harris, Barbara S. Fox, Theadore Ptak et al.|Journal of Crohn s and Colitis|2016Cited by 75
Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative ColitisDeborah Hartman, Barbara S. Fox, Daniel E. Tracey et al.|Journal of Crohn s and Colitis|2016Cited by 33
Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) diseaseThomas Girard, Jorge Di Paola, Gwendalyn J. Randolph et al.|Journal of Thrombosis and Haemostasis|2023Cited by 30